Ratings by Goldman Sachs (Graig Suvannavejh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | Autolus Therapeutics plc | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Valneva SE | VALN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/20/2024 | Valneva SE | VALN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2024 | Autolus Therapeutics plc | AUTL | Upgrade | Buy (Neutral) |
3.08 (1.58) |
-48.7% | Details | |
| 1/26/2024 | Valneva SE | VALN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/13/2023 | Autolus Therapeutics plc | AUTL | Maintain | Neutral (N/A) |
|
Details | ||
| 6/7/2023 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Autolus Therapeutics plc | AUTL | Maintain | Neutral (N/A) |
|
Details | ||
| 9/23/2022 | Valneva SE | VALN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2022 | Halozyme Therapeutics | halo | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | TG Therapeutics | TGTX | Downgrade | Sell (Neutral) |
33.17 (10.49) |
-68.38% | Details | |
| 11/9/2021 | AUTL | AUTL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2021 | Horizon Therapeutics | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2021 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Vor Biopharma, Inc. | VOR | Maintain | Sell (N/A) |
|
Details | ||
| 8/5/2021 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | Rhythm Pharmaceuticals | RYTM | Maintain | Sell (N/A) |
|
Details | ||
| 8/3/2021 | TG Therapeutics | TGTX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2021 | Cytokinetics | CYTK | Maintain | Neutral (N/A) |
|
Details | ||
| 7/13/2021 | Ambrix Biopharma | AMAM | New Coverage | Buy (N/A) |
21.32 (28.00) |
31.33% | Details | |
| 7/13/2021 | Ambrx Biopharma | AMAM | New Coverage | Buy (N/A) |
21.32 (28.00) |
31.33% | Details | |
| 6/30/2021 | Cerevel Therapeutics | CERE | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2021 | Valneva SE | VALN | New Coverage | Buy (N/A) |
25.98 (6.04) |
-76.75% | Details | |
| 5/18/2021 | Rain Therapeutics | RAIN | New Coverage | Buy (N/A) |
15.33 (1.97) |
-87.15% | Details | |
| 5/14/2021 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/12/2021 | Tricida | TCDA | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/20/2021 | TG Therapeutics | TGTX | New Coverage | Neutral (N/A) |
44.78 (53.31) |
19.05% | Details | |
| 4/20/2021 | Design Therapeutics Inc | DSGN | New Coverage | Neutral (N/A) |
23.50 (15.64) |
-33.45% | Details | |
| 4/19/2021 | Edgewise Therapeutics | EWTX | New Coverage | Neutral (N/A) |
27.91 (39.56) |
41.74% | Details | |
| 3/29/2021 | Harmony Biosciences Holdings Inc. | HRMY | Upgrade | Buy (Neutral) |
27.56 (54.70) |
98.48% | Details | |
| 3/11/2021 | Flexion Therapeutics | FLXN | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/10/2021 | Athira Pharma | ATHA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/8/2021 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 3/8/2021 | Cimarex Energy | XEC | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Terns Pharmaceuticals | TERN | New Coverage | Buy (N/A) |
24.64 (11.12) |
-54.87% | Details | |
| 3/2/2021 | Immunocore Holdings | IMCR | New Coverage | Neutral (N/A) |
48.36 (32.50) |
-32.8% | Details | |
| 3/2/2021 | Gemini Therapeutics Inc. | GMTX | New Coverage | Buy (N/A) |
15.20 (1.35) |
-91.12% | Details | |
| 3/2/2021 | Vor Biopharma, Inc. | VOR | New Coverage | Sell (N/A) |
44.96 (20.59) |
-54.2% | Details | |
| 2/25/2021 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2021 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Cimarex Energy | XEC | Maintain | Neutral (N/A) |
|
Details | ||
| 12/16/2020 | Cimarex Energy | XEC | Upgrade | Buy (Neutral) |
38.48 (87.20) |
126.61% | Details | |
| 12/10/2020 | Cimarex Energy | XEC | Maintain | Neutral (N/A) |
|
Details | ||
| 12/10/2020 | Ceres | CERE | New Coverage | Buy (N/A) |
16.06 (30.63) |
90.72% | Details | |
| 11/13/2020 | Kodiak Sciences Inc. | KOD | Downgrade | Neutral (Buy) |
119.99 (38.54) |
-67.88% | Details | |
| 11/11/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Sell (N/A) |
|
Details | ||
| 11/9/2020 | Arcutis Biotherapeutics Inc. | ARQT | Upgrade | Buy (Neutral) |
18.66 (25.81) |
38.32% | Details | |
| 10/29/2020 | Cytokinetics | CYTK | New Coverage | Neutral (N/A) |
16.33 (86.49) |
429.64% | Details | |
| 10/20/2020 | Prelude Therapeutics | PRLD | New Coverage | Neutral (N/A) |
31.00 (4.47) |
-85.58% | Details | |
| 9/21/2020 | Immatics | IMTX | New Coverage | Buy (N/A) |
9.19 (9.95) |
8.27% | Details | |
| 9/14/2020 | Jazz Pharmaceuticals | JAZZ | Downgrade | Sell (Neutral) |
139.10 (133.09) |
-4.32% | Details | |
| 9/14/2020 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Neutral (N/A) |
44.39 (37.26) |
-16.06% | Details | |
| 8/25/2020 | Tricida | TCDA | Downgrade | Neutral (Buy) |
10.11 (0.11) |
-98.91% | Details | |
| 8/20/2020 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2020 | Flexion Therapeutics | FLXN | New Coverage | Neutral (N/A) |
12.54 (24.96) |
99.04% | Details | |
| 8/7/2020 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 6/16/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2020 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | AUTL | AUTL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2020 | Portola Pharmaceuticals | PTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2020 | Momenta Pharmaceuticals | MNTA | New Coverage | Neutral (N/A) |
29.15 (52.48) |
80.03% | Details | |
| 3/3/2020 | Kodiak Sciences Inc. | KOD | New Coverage | Buy (N/A) |
63.97 (38.54) |
-39.75% | Details | |
| 3/2/2020 | Portola Pharmaceuticals | PTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2020 | Horizon Therapeutics | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2020 | Arcutis Biotherapeutics Inc. | ARQT | New Coverage | Neutral (N/A) |
27.05 (25.81) |
-4.58% | Details | |
| 2/5/2020 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2020 | Portola Pharmaceuticals | PTLA | Maintain | Neutral (N/A) |
|
Details | ||
| 1/8/2020 | Rhythm Pharmaceuticals | RYTM | New Coverage | Sell (N/A) |
22.34 (114.17) |
411.06% | Details | |
| 1/8/2020 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
18.05 (79.45) |
340.17% | Details | |
| 1/8/2020 | Horizon Therapeutics | HZNP | New Coverage | Neutral (N/A) |
36.22 (108.08) |
198.4% | Details | |
| 11/8/2019 | Portola Pharmaceuticals | PTLA | New Coverage | Neutral (N/A) |
28.41 (18.03) |
-36.54% | Details | |
| 11/1/2019 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Krystal Biotech | KRYS | New Coverage | Neutral (N/A) |
48.98 (61.09) |
24.72% | Details | |
| 9/11/2019 | Bicycle Therapeutics | BCYC | Upgrade | Buy (Neutral) |
7.15 (4.35) |
-39.16% | Details | |
| 9/3/2019 | Insmed | INSM | New Coverage | Buy (N/A) |
16.44 (111.60) |
578.83% | Details | |
| 6/27/2019 | Tricida | TCDA | New Coverage | Buy (N/A) |
35.15 (0.11) |
-99.69% | Details | |
| 6/17/2019 | Bicycle Therapeutics | BCYC | New Coverage | Neutral (N/A) |
12.40 (7.15) |
-42.34% | Details | |
| 12/17/2018 | Orchard Therapeutics | ORTX | Upgrade | Buy (Neutral) |
15.00 (16.70) |
11.33% | Details | |
| 12/17/2018 | Zealand Pharma A/S | ZEAL | Downgrade | Neutral (Buy) |
13.09 (17.59) |
34.38% | Details | |
| 11/26/2018 | Orchard Therapeutics | ORTX | New Coverage | Neutral (N/A) |
16.04 (15.00) |
-6.48% | Details |
